萨拉卡提尼布通过准MLKL来抑制亡并改善牛皮炎症
Jingyi Li1, Xingfeng Liu1, Yuanyuan Liu1
1The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Cell death & disease
|February 8, 2024
概括
萨拉卡提尼布通过向MLKL蛋白质,有效地抑制亡,一种编程细胞死亡形式. 这一发现为像牛皮这样的炎症性皮肤疾病提供了有希望的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亡,一个被编程的细胞死亡途径,释放炎症信号,导致诸如皮肤炎症等疾病.
- 瘤亡因子α (TNF) 诱导的亡的特征是RIPK1,RIPK3和MLKL的激活.
- 目前对死相关炎症的治疗策略是有限的.
研究的目的:
- 为了识别抑制TNF诱导的亡的小分子.
- 阐明已识别的化合物发挥其抑制作用的机制.
- 在皮肤炎症的临床前模型中评估这些化合物的治疗潜力.
主要方法:
- 对小分子化合物库的选,以识别TNF诱导亡的抑制剂.
- 生物化学试验评估化合物对MLKL酸化,转位和寡合化的影响.
- 在体内研究,使用伊米基莫德 (IMQ) 诱导的牛皮小鼠模型来评估治疗疗效.
主要成果:
- 萨拉卡提尼布被确定为TNF诱导亡的强有力的抑制剂.
- 萨拉卡提尼布向MLKL,防止其酸化,转位和寡合化.
- 在牛皮的小鼠模型中,萨拉卡提尼布有效地降低了MLKL酸化和炎症反应.
结论:
- 萨拉卡提尼布通过直接向MLKL来抑制亡.
- 这些研究结果表明,萨拉卡提尼布作为一种潜在的治疗药物,可以治疗死驱动的炎症性疾病,包括牛皮.
- 准MLKL代表了管理皮肤炎症的可行策略.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
416
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
2.2K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
